World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China
China’s National Medical Products (NMPA) has approved an investigational new drug application from IASO Bio…
August 19, 2022 - 2 minutes
News and Trends
Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek
This week our guests on the podcast are Xianghao Zuo, deputy director of R&D at…
August 19, 2022 - 3 minutes
Interview
How re-engineering antibodies can prevent allergies
The California startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies…
August 19, 2022 - 9 minutes
Best in Biotech
Five emerging biotech hubs in the Asia-Pacific region
The Asia-Pacific (APAC) region is the third largest pharmaceutical market in the world, and has…
August 19, 2022 - 7 minutes
What's New
MoreKrystal Biotech’s gets FDA go-ahead for dystrophic epidermolysis bullosa treatment
U.S. gene therapy company Krystal Biotech, Inc. has announced that the US Food and Drug…
August 19, 2022 - 3 minutes
axsome therapeutics’ MDD treatment gets green light from FDA
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics, Inc.’s Auvelity tablets for…
August 19, 2022 - 4 minutes
Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
August 19, 2022 - 3 minutes
Delaying menopause could slow the aging process
After decades of neglect, women’s health is attracting increasing interest in the biotech industry. The…
August 19, 2022 - 6 minutes
Treatment for patients with fragile skin disease accepted by FDA
The U.S. Food and Drug Administration (FDA) has accepted the filing of a biologic license…
August 19, 2022 - 3 minutes
Nuance Pharma receives clearance to begin clinical trials with Ensifentrine in China
Nuance Pharma and its partner Verona Pharma plc have received clearance from the Center of…
August 19, 2022 - 2 minutes
Aeglea BioTherapeutics’ arginine 1 deficiency treatment gets EMA ok
Aeglea BioTherapeutics, Inc. says its marketing authorization application (MAA) for pegzilarginase for the treatment of…
August 19, 2022 - 3 minutes
First patient on Innovative Cellular Therapeutics’ study looking at treating colorectal cancer
The first patient has been enrolled on a study to trial a treatment for relapsed…
August 18, 2022 - 2 minutes
From Our Partners
View More
Sponsored
by ProteoGenix
Optimizing bioproduction using transient expression systems
Sponsored
by Merck
How efficient lab inventory management can become a driver for success
Sponsored
by Medpace
A toolkit for emerging biotechs: practical advice for navigating challenges and advancing clinical development
Sponsored
by WuXi Advanced Therapies
Streamlining CAR-T cell therapy manufacturing: a platform approach
Download our industry reports
View all our reports
